Here are eight highlights:
1. Smith & Nephew saw revenue of about $1.19 billion in the second quarter of 2017.
2. In the second quarter, the company saw a 13 percent jump in emerging market revenue.
3. Smith & Nephew recorded strong growth in knee implants ($246 million) and advanced wound devices ($49 million) for the second quarter of 2017.
4. The sports medicine, trauma and other segment saw revenue of $480 million in the second quarter of 2017.
5. The company’s first half of 2017 revenue was about $2.33 billion.
6. The first half of 2017’s operating profit was $414 million, with an operating profit margin of 17.7 percent.
7. The company’s trading profit for the first half of 2017 was $493 million, with a trading profit margin of 21.1 percent.
8. Smith & Nephew had $438 million in cash generated from operating activities.
More articles on devices:
Integra LifeSciences saw $282.2M Q2 revenue — 6 observations
FDA clears CTL’s MATISSE Titanium ACIF Cage: 4 things to know
WishBone Medical reveals Exact Osteotomy System for pediatric orthopedic surgery cuts — 5 points
